-
公开(公告)号:SI1040097T1
公开(公告)日:2004-10-31
申请号:SI9830659
申请日:1998-12-16
Applicant: ABBOTT LAB
Inventor: CARROLL WILLIAM A , HOLLADAY MARK W , SULLIVAN JAMES P , DRIZIN IRENE , ZHANG HENRY Q
IPC: A61K31/38 , A61K31/44 , A61K31/47 , C07D211/84 , C07D215/36 , C07D495/04 , C07D495/14
-
公开(公告)号:BG64309B1
公开(公告)日:2004-09-30
申请号:BG10459400
申请日:2000-07-11
Applicant: ABBOTT LAB
Inventor: CARROL WILLIAM A , HOLLADAY MARK W , SULLIVAN JAMES P , DRIZIN IRENE , ZHANG HENRY Q
IPC: A61K31/4365 , A61K31/47 , A61K31/4743 , A61P1/00 , A61P1/14 , A61P9/08 , A61P9/12 , A61P11/06 , A61P13/02 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , C07C45/29 , C07D215/36 , C07D221/04 , C07D495/04 , C07D495/14 , C07D211/84 , A61K31/44 , A61K31/38
Abstract: The invention relates to compounds with the formula wherein the radicals have the meanings given in the description. They are useful in prevention, alleviation and treatment of diseases which are affected by potassium channel openers. The invention also relates to the application of the compounds for the preparation of medicamentous form, for opening potassium channels in mammals. 39 claims
-
公开(公告)号:PE05182004A1
公开(公告)日:2004-08-24
申请号:PE0005042003
申请日:2003-05-23
Applicant: ABBOTT LAB
Inventor: HAKEEM AHMED A , MORTELL KATHLEEN H , KOLASA TEODOZYJ , PATEL MEENA V , XIA ZHIREN , DAANEN JEROME F , WANG XUEQING , ZHANG HENRY Q , STEWART ANDREW O , MATULENKO MARK A , BHATIA PRAMILA A
IPC: A61K31/00
Abstract: SE REFIERE A UN COMPUESTO DE FORMULA I COMO SAL, ESTER, O AMIDA, ENTRE OTROS; DONDE A ES ARILO, ARILALQUILO, CICLOALQUILO, ENTRE OTROS; L ES -(R7)C(O)-, -C(O)N(R7)-, N(R7)C(S) Y -C(S)N(R7)-; D ES ALQUILENO, FLUOROALQUILENO E HIDROXIALQUILENO; Z ES N, C Y CRB; RA ES H Y ALQUILO; RB ES H, ALQUILO Y HALOGENO; LA LINEA PUNTEADA ES UNA UNION CUANDO Z ES C Y ESTA AUSENTE CUANDO Z ES N O CRB; B ES (A), (B), (C), ENTRE OTROS; DONDE R1, R2, R3, R4, R5 SON INDEPENDIENTEMENTE H, ALCOXI, ALQUILENO, CIANO, ENTRE OTROS; R7 ES H Y ALQUILO. SON COMPUESTOS PREFERIDOS: 2-[4-(2-METOXIFENIL)-1-PIPERAZINIL]-N-(3-METILFENIL)ACETAMIDA, 2-[4-(2-CIANOFENIL)-1-PIPERAZINIL]-N-(3-METILFENIL)ACETAMIDA Y N-(3-METILFENIL)-2-[4-(2-PIRIMIDINIL)-1-PIPERAZINIL]ACETAMIDA, ENTRE OTROS. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE LAS DISFUNCIONES SEXUALES INCLUYENDO LA DISFUNCION ERECTIL MASCULINA
-
公开(公告)号:AU756505B2
公开(公告)日:2003-01-16
申请号:AU1830799
申请日:1998-12-16
Applicant: ABBOTT LAB
Inventor: CARROLL WILLIAM A , HOLLADAY MARK W , SULLIVAN JAMES P , DRIZIN IRENE , ZHANG HENRY Q
IPC: A61K31/4365 , A61K31/47 , A61K31/4743 , A61P1/00 , A61P1/14 , A61P9/08 , A61P9/12 , A61P11/06 , A61P13/02 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , C07C45/29 , C07D215/36 , C07D221/04 , C07D495/04 , C07D495/14 , C07D211/84 , A61K31/38 , A61K31/44
Abstract: Compounds having the formula are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
-
公开(公告)号:CA2437405A1
公开(公告)日:2002-08-15
申请号:CA2437405
申请日:2002-01-17
Applicant: ABBOTT LAB
Inventor: HUANG PEGGY P , KINCAID JOHN F , ALTENBACH ROBERT J , BRIONI JORGE D , KYM PHILIP R , ZHANG HENRY Q , PEREZ-MEDRANO ARTURO , HOLLADAY MARK W , KORT MICHAEL E , LYNCH JOHN K , GREGG ROBERT J , BAI HAO , CARROLL WILLIAM A , GOPALAKRISHNAN MURALI
IPC: A61K31/17 , A61K31/275 , A61K31/4164 , A61K31/4406 , A61K31/455 , A61K31/47 , A61K31/505 , A61P1/00 , A61P9/00 , A61P9/04 , A61P9/10 , A61P11/00 , A61P11/06 , A61P13/00 , A61P13/08 , A61P13/10 , A61P15/00 , A61P15/06 , A61P15/10 , A61P17/00 , A61P17/14 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/18 , A61P25/28 , A61P43/00 , C07C233/36 , C07C233/78 , C07C233/83 , C07C255/61 , C07C271/22 , C07C275/28 , C07C275/30 , C07C279/28 , C07C279/36 , C07C335/16 , C07C335/18 , C07C335/20 , C07D209/08 , C07D209/30 , C07D213/40 , C07D213/74 , C07D213/75 , C07D213/82 , C07D215/38 , C07D233/42 , C07D233/84 , C07D235/06 , C07D239/42 , C07D333/20 , C07D401/04 , C07D401/12 , C07D405/12 , C07D409/12
Abstract: Compounds of formula (I) are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
-
公开(公告)号:HU0100112A2
公开(公告)日:2001-08-28
申请号:HU0100112
申请日:1998-12-16
Applicant: ABBOTT LAB
Inventor: CARROLL WILLIAM A , DRIZIN IRENE , HOLLADAY MARK W , SULLIVAN JAMES P , ZHANG HENRY Q
IPC: A61K31/4365 , A61K31/47 , A61K31/4743 , A61P1/00 , A61P1/14 , A61P9/08 , A61P9/12 , A61P11/06 , A61P13/02 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , C07C45/29 , C07D215/36 , C07D221/04 , C07D495/04 , C07D495/14 , C07D211/84
Abstract: Compounds having the formula are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
-
公开(公告)号:CO5040063A1
公开(公告)日:2001-05-29
申请号:CO98074895
申请日:1998-12-16
Applicant: ABBOTT LAB
Inventor: CARROLL WILLIAM A , HOLLADAY MARK W , SULLIVAN JAMES P , DRIZIN IRENE , ZHANG HENRY Q
IPC: A61K31/34 , A61K31/38 , A61K31/44 , A61K31/47 , C07C45/29 , C07D215/36 , C07D221/04 , C07D495/04 , C07D495/14
Abstract: Un compuesto de fórmula Ió una sal, éster, amida, ó precursor de droga farmacéuticamente aceptables de éste.en dondeR1 es alquil;R2 se selecciona del grupo conformado por aril y heteroaril: en donde el aril está opcionalmente sustituido con 1-5 sustituyentes independientemente seleccionados entre alcanoil, alquenil, alcoxi, alcoxialcoxi, alquil, alquilsulfinil, alquilsulfonil, alcoxicarbonil, alquinil, aril, azido, carboxi, ciano, halo, haloalquil, haloalcoxi, heteroaril, hidroxi, nitro tioalcoxi, -C(O)NR6 R7 (en donde R6 y R7 son independientemente hidrógeno, alquil ó aril), tioureido, ureido y -S(O)p NR6 R7 ó el heteroaril esta opcionalmente sustituido con 1-4 sustituyentes independientemente seleccionados entre alcanoil, alquenil, alcoxi, alquil, alquilsulfinil,alquilsulfonil, alcoxicarbonil, alquinil, aril, azido, carboxi, ciano, halo, haloalquil, haloalcoxi, heteroaril, hidroxi, hidroxialquil, nitro, tioalcoxi, -C(O)NR6 R7 (en donde R6 y R7 son independientemente hidrógeno, alquil o aril), tioureido, ureido, y -S(O)p NR6 R7 .;n es O-2;A se selecciona del grupo conformado por hidrógeno, alquil, y -X-R3 ;en donde R3 es alquil o haloalquil; X es -CO(O)- ó -S(O)p - en donde p es 1-2;R4 y R5 se seleccionan independientemente del grupo conformado por hidrógeno, alquil y haloalquil; óR1 y R5 junto con el anillo al cual van ligados forman un anillo que contiene azufre de 5, 6 ó 7 miembros con 1 ó 2 dobles enlaces y con O - 2sustituyentes oxo; óA y R4 junto con el anillo al cual van ligados forman un anillo seleccionado del grupo conformado por un anillo carbocíclico de 5, 6 ó 7 miembros con1 ó 2 dobles enlaces y 0 ó 1 sustituyente oxo y un anillo que contiene azufre de 5, 6 ó 7 miembros con 1 ó 2 dobles enlaces y con O - 2 sustituyentesoxo, a condición de que por lo menos uno de los sustituyentes R1 y R5 ó A y R4 forman un anillo.
-
公开(公告)号:PL341298A1
公开(公告)日:2001-04-09
申请号:PL34129898
申请日:1998-12-16
Applicant: ABBOTT LAB
Inventor: CARROLL WILLIAM A , HOLLADAY MARK W , SULLIVAN JAMES P , DRIZIN IRENE , ZHANG HENRY Q
IPC: A61K31/4365 , A61K31/47 , A61K31/4743 , A61P1/00 , A61P1/14 , A61P9/08 , A61P9/12 , A61P11/06 , A61P13/02 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , C07C45/29 , C07D215/36 , C07D221/04 , C07D495/04 , C07D495/14 , C07D211/84 , A61K31/44 , A61K31/38
Abstract: Compounds having the formula are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
-
公开(公告)号:AU1830799A
公开(公告)日:1999-07-05
申请号:AU1830799
申请日:1998-12-16
Applicant: ABBOTT LAB
Inventor: CARROLL WILLIAM A , HOLLADAY MARK W , SULLIVAN JAMES P , DRIZIN IRENE , ZHANG HENRY Q
IPC: A61K31/4365 , A61K31/47 , A61K31/4743 , A61P1/00 , A61P1/14 , A61P9/08 , A61P9/12 , A61P11/06 , A61P13/02 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , C07C45/29 , C07D215/36 , C07D221/04 , C07D495/04 , C07D495/14 , C07D211/84 , A61K31/44 , A61K31/38
Abstract: Compounds having the formula are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
-
-
-
-
-
-
-
-